{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:50:24Z","timestamp":1787032224590,"version":"build-2736575974"},"reference-count":71,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5797\/jnet.ra.2026-0017","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:11:15Z","timestamp":1775513475000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology, Pathophysiology, and Medical Management of Intracranial Atherosclerotic Disease"],"prefix":"10.5797","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-457X","authenticated-orcid":false,"given":"Ryo","family":"Itabashi","sequence":"first","affiliation":[{"name":"Stroke Center, Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Yahaba, Iwate, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gutierrez J, Turan TN, Hoh BL, et al. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. <i>Lancet Neurol<\/i> 2022; 21: 355\u2013368.","DOI":"10.1016\/S1474-4422(21)00376-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chen LH, Spagnolo-Allende A, Yang D, et al. Epidemiology, pathophysiology, and imaging of atherosclerotic intracranial disease. <i>Stroke<\/i> 2024; 55: 311\u2013323.","DOI":"10.1161\/STROKEAHA.123.043630"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bos D, Portegies ML, van der Lugt A, et al. Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam Study. <i>JAMA Neurol<\/i> 2014; 71: 405\u2013411.","DOI":"10.1001\/jamaneurol.2013.6223"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Suwanwela NC, Chutinetr AJN. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. <i>Neuroepidemiology<\/i> 2003; 22: 37\u201340.","DOI":"10.1159\/000067112"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Moustafa RR, Moneim AA, Salem HH, et al. Intracranial steno-occlusive arterial disease and its associations in Egyptian ischemic stroke patients. <i>Stroke<\/i> 2013; 44: 538\u2013541.","DOI":"10.1161\/STROKEAHA.112.679050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kim BS, Chung PW, Park KY, et al. Burden of intracranial atherosclerosis is associated with long-term vascular outcome in patients with ischemic stroke. <i>Stroke<\/i> 2017; 48: 2819\u20132826.","DOI":"10.1161\/STROKEAHA.117.017806"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. <i>Stroke<\/i> 2014; 45: 663\u2013669.","DOI":"10.1161\/STROKEAHA.113.003508"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sylaja PN, Pandian JD, Kaul S, et al. Ischemic stroke profile, risk factors, and outcomes in India: the Indo-US Collaborative Stroke Project. <i>Stroke<\/i> 2018; 49: 219\u2013222.","DOI":"10.1161\/STROKEAHA.117.018700"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shin DH, Lee PH, Bang OY. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. <i>Arch Neurol<\/i> 2005; 62: 1232\u20131237.","DOI":"10.1001\/archneur.62.8.1232"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kim BS, Jung HS, Bang OY, et al. Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. <i>Atherosclerosis<\/i> 2010; 212: 682\u2013688.","DOI":"10.1016\/j.atherosclerosis.2010.07.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lee SJ, Lee DG. Distribution of atherosclerotic stenosis determining early neurologic deterioration in acute ischemic stroke. <i>PLoS One<\/i> 2017; 12: e0185314.","DOI":"10.1371\/journal.pone.0185314"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hoshino T, Sissani L, Labreuche J, et al. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. <i>JAMA Neurol<\/i> 2018; 75: 203\u2013211.","DOI":"10.1001\/jamaneurol.2017.3960"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bang OY, Saver JL, Liebeskind DS, et al. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group. <i>J Neurol Sci<\/i> 2009; 284: 40\u201345.","DOI":"10.1016\/j.jns.2009.03.033"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) White H, Boden-Albala B, Wang C, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. <i>Circulation<\/i> 2005; 111: 1327\u20131331.","DOI":"10.1161\/01.CIR.0000157736.19739.D0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Leng X, Hurford R, Feng X, et al. Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review. <i>J Neurol Neurosurg Psychiatry<\/i> 2021; 92: 590\u2013597.","DOI":"10.1136\/jnnp-2020-325630"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Shu MJ, Zhai FF, Zhang DD, et al. Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations. <i>Stroke Vasc Neurol<\/i> 2021; 6: 589\u2013594.","DOI":"10.1136\/svn-2020-000813"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Li S, Tang M, Zhang D, et al. The prevalence and prognosis of asymptomatic intracranial atherosclerosis in a community-based population: results based on high-resolution magnetic resonance imaging. <i>Eur J Neurol<\/i> 2023; 30: 3761\u20133771.","DOI":"10.1111\/ene.16057"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang Y, Cai X, Li H, et al. Association of intracranial atherosclerosis with cerebral small vessel disease in a community-based population. <i>Eur J Neurol<\/i> 2023; 30: 2700\u20132712.","DOI":"10.1111\/ene.15908"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Han X, Pan Y, Li J, et al. Association of hepatic steatosis index with asymptomatic intracranial arterial stenosis: a cross-sectional study. <i>Neurol Sci<\/i> 2026; 47: 104.","DOI":"10.1007\/s10072-025-08592-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Planas-Ballv\u00e9 A, Crespo AM, Aguilar LM, et al. The Barcelona-Asymptomatic Intracranial Atherosclerosis Study: subclinical intracranial atherosclerosis as predictor of long-term vascular events. <i>Atherosclerosis<\/i> 2019; 282: 132\u2013136.","DOI":"10.1016\/j.atherosclerosis.2019.01.022"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Suri MF, Qiao Y, Ma X, et al. Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the atherosclerosis risk in communities study. <i>Stroke<\/i> 2016; 47: 1187\u20131193.","DOI":"10.1161\/STROKEAHA.115.011292"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Gutierrez J, Khasiyev F, Liu M, et al. Determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis. <i>J Am Coll Cardiol<\/i> 2021; 78: 562\u2013571.","DOI":"10.1016\/j.jacc.2021.05.041"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hurford R, Wolters FJ, Li L, et al. Prognosis of asymptomatic intracranial stenosis in patients with transient ischemic attack and minor stroke. <i>JAMA Neurol<\/i> 2020; 77: 947\u2013954.","DOI":"10.1001\/jamaneurol.2020.1326"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. <i>N Engl J Med<\/i> 2005; 352: 1305\u20131316.","DOI":"10.1056\/NEJMoa043033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. <i>Circulation<\/i> 2006; 113: 555\u2013563.","DOI":"10.1161\/CIRCULATIONAHA.105.578229"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. <i>Lancet<\/i> 2014; 383: 333\u2013341.","DOI":"10.1016\/S0140-6736(13)62038-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. <i>JAMA<\/i> 2015; 313: 1240\u20131248.","DOI":"10.1001\/jama.2015.1693"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Gao P, Wang T, Wang D, et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial. <i>JAMA<\/i> 2022; 328: 534\u2013542.","DOI":"10.1001\/jama.2022.18921"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sun X, Deng Y, Zhang Y, et al. Balloon angioplasty vs medical management for intracranial artery stenosis: the BASIS randomized clinical trial. <i>JAMA<\/i> 2024; 332: 1059\u20131069.","DOI":"10.1001\/jama.2024.12829"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hurford R, Wolters FJ, Li L, et al. Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study. <i>Lancet Neurol<\/i> 2020; 19: 413\u2013421.","DOI":"10.1016\/S1474-4422(20)30079-X"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Matsui R, Nakagawa T, Takayoshi H, et al. A prospective study of asymptomatic intracranial atherosclerotic stenosis in neurologically normal volunteers in a Japanese cohort. <i>Front Neurol<\/i> 2016; 7: 39.","DOI":"10.3389\/fneur.2016.00039"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Gutierrez J, Gil-Guevara A, Ramaswamy S, et al. Classification of covert brain infarct subtype and risk of death and vascular events. <i>Stroke<\/i> 2020; 51: 90\u201398.","DOI":"10.1161\/STROKEAHA.119.026068"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. <i>Arterioscler Thromb Vasc Biol<\/i> 2000; 20: 1262\u20131275.","DOI":"10.1161\/01.ATV.20.5.1262"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Gutierrez J, Goldman J, Honig LS, et al. Determinants of cerebrovascular remodeling: do large brain arteries accommodate stenosis? <i>Atherosclerosis<\/i> 2014; 235: 371\u2013379.","DOI":"10.1016\/j.atherosclerosis.2014.05.925"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ogata J, Masuda J, Yutani C, et al. Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. <i>J Neurol Neurosurg Psychiatry<\/i> 1994; 57: 17\u201321.","DOI":"10.1136\/jnnp.57.1.17"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) D\u2019Armiento FP, Bianchi A, de Nigris F, et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. <i>Stroke<\/i> 2001; 32: 2472\u20132479.","DOI":"10.1161\/hs1101.098520"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Okazaki S, Morimoto T, Kamatani Y, et al. Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis. <i>Circulation<\/i> 2019; 139: 295\u2013298.","DOI":"10.1161\/CIRCULATIONAHA.118.038439"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Caplan LR, Wong KS, Gao S, et al. Is hypoperfusion an important cause of strokes? If so, how? <i>Cerebrovasc Dis<\/i> 2006; 21: 145\u2013153.","DOI":"10.1159\/000090791"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. <i>Ann Neurol<\/i> 2002; 52: 74\u201381.","DOI":"10.1002\/ana.10250"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Masuda J, Yutani C, Ogata J, et al. Atheromatous embolism in the brain: a clinicopathologic analysis of 15 autopsy cases. <i>Neurology<\/i> 1994; 44: 1231\u20131237.","DOI":"10.1212\/WNL.44.7.1231"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Wong KS, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. <i>Lancet Neurol<\/i> 2010; 9: 489\u2013497.","DOI":"10.1016\/S1474-4422(10)70060-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Liu L, Wong KS, Leng X, et al. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. <i>Neurology<\/i> 2015; 85: 1154\u20131162.","DOI":"10.1212\/WNL.0000000000001972"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Amarenco P, Denison H, Evans SR, et al. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. <i>Stroke<\/i> 2020; 51: 3504\u20133513.","DOI":"10.1161\/STROKEAHA.120.032239"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Fujimoto S, Iguchi Y, Yamagami H, et al. P2Y<sub>12<\/sub> reaction units with prasugrel in acute large artery atherosclerosis and transient ischemic attack: an open-label randomized controlled study, ACUTE-PRAS. <i>Circ J<\/i> 2025; 89: 1922\u20131930.","DOI":"10.1253\/circj.CJ-24-0949"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Rahman H, Khan SU, Nasir F, et al. Optimal duration of aspirin plus clopidogrel after ischemic stroke or transient ischemic attack. <i>Stroke<\/i> 2019; 50: 947\u2013953.","DOI":"10.1161\/STROKEAHA.118.023978"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Abdul Rahman L, Turan TN, Cotsonis G, et al. Dual antiplatelet therapy beyond 90 days in symptomatic intracranial stenosis in the SAMMPRIS trial. <i>J Stroke Cerebrovasc Dis<\/i> 2020; 29: 105254.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105254"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Uchiyama S, Toyoda K, Omae K, et al. Dual antiplatelet therapy using cilostazol in patients with stroke and intracranial arterial stenosis. <i>J Am Heart Assoc<\/i> 2021; 10: e022575.","DOI":"10.1161\/JAHA.121.022575"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Zhang X, Zhong W, Xue R, et al. Argatroban in patients with acute ischemic stroke with early neurological deterioration: a randomized clinical trial. <i>JAMA Neurol<\/i> 2024; 81: 118\u2013125.","DOI":"10.1001\/jamaneurol.2023.5093"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Kitagawa K, Yamamoto Y, Arima H, et al. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. <i>JAMA Neurol<\/i> 2019; 76: 1309\u20131318.","DOI":"10.1001\/jamaneurol.2019.2167"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Turan TN, Cotsonis G, Lynn MJ, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. <i>Circulation<\/i> 2007; 115: 2969\u20132975.","DOI":"10.1161\/CIRCULATIONAHA.106.622464"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Park JM, Kim BJ, Kwon SU, et al. Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial. <i>J Hypertens<\/i> 2018; 36: 1936\u20131941.","DOI":"10.1097\/HJH.0000000000001784"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Yamauchi H, Higashi T, Kagawa S, et al. Impaired perfusion modifies the relationship between blood pressure and stroke risk in major cerebral artery disease. <i>J Neurol Neurosurg Psychiatry<\/i> 2013; 84: 1226\u20131232.","DOI":"10.1136\/jnnp-2013-305159"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Zhou P, Lu Z, Gao P, et al. Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up. <i>Clin Neurol Neurosurg<\/i> 2014; 120: 6\u201313.","DOI":"10.1016\/j.clineuro.2014.02.001"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Amarenco P, Kim JS, Labreuche J, et al. A comparison of two LDL cholesterol targets after ischemic stroke. <i>N Engl J Med<\/i> 2020; 382: 9\u201319.","DOI":"10.1056\/NEJMoa1910355"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Sangha RS, Naidech AM, Corado C, et al. Challenges in the medical management of symptomatic intracranial stenosis in an urban setting. <i>Stroke<\/i> 2017; 48: 2158\u20132163.","DOI":"10.1161\/STROKEAHA.116.016254"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Arenillas JF, Molina C, Chacon P, et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. <i>Neurology<\/i> 2004; 63: 27\u201332.","DOI":"10.1212\/01.WNL.0000132637.30287.B4"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Weimar C, Goertler M, Harms L, et al. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. <i>Arch Neurol<\/i> 2006; 63: 1287\u20131291.","DOI":"10.1001\/archneur.63.9.1287"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Rincon F, Sacco RL, Kranwinkel G, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. <i>Cerebrovasc Dis<\/i> 2009; 28: 65\u201371.","DOI":"10.1159\/000219299"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Homburg PJ, Plas GJ, Rozie S, et al. Prevalence and calcification of intracranial arterial stenotic lesions as assessed with multidetector computed tomography angiography. <i>Stroke<\/i> 2011; 42: 1244\u20131250.","DOI":"10.1161\/STROKEAHA.110.596254"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Sharma VK, Tsivgoulis G, Teoh HL, et al. Stroke risk factors and outcomes among various Asian ethnic groups in Singapore. <i>J Stroke Cerebrovasc Dis<\/i> 2012; 21: 299\u2013304.","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.08.010"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Ovesen C, Abild A, Christensen AF, et al. Prevalence and long-term clinical significance of intracranial atherosclerosis after ischaemic stroke or transient ischaemic attack: a cohort study. <i>BMJ Open<\/i> 2013; 3: e003724.","DOI":"10.1136\/bmjopen-2013-003724"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Logallo N, Naess H, Waje-Andreassen U, et al. Prevalence of intracranial stenosis in a Norwegian ischemic stroke population. <i>J Stroke Cerebrovasc Dis<\/i> 2014; 23: 1611\u20131615.","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.049"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Tsivgoulis G, Vadikolias K, Heliopoulos I, et al. Prevalence of symptomatic intracranial atherosclerosis in Caucasians: a prospective, multicenter, transcranial Doppler study. <i>J Neuroimaging<\/i> 2014; 24: 11\u201317.","DOI":"10.1111\/j.1552-6569.2012.00707.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Sorgun MH, Yilmaz V, Ulukan C, et al. Prevalence and prognosis of intracranial stenosis in acute ischemic stroke; a single center registry from Turkey. <i>Turk J Med Sci<\/i> 2017; 47: 1072\u20131077.","DOI":"10.3906\/sag-1510-21"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Lange MC, Ribas G, Scavasine V, et al. Stroke recurrence in the different subtypes of ischemic stroke. The importance of the intracranial disease. <i>Arq Neuropsiquiatr<\/i> 2018; 76: 649\u2013653.","DOI":"10.1590\/0004-282x20180095"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Wang X, Zhao Y, Ji X, et al. Kongcun Town Asymptomatic Intracranial Artery Stenosis study in Shandong, China: cohort profile. <i>BMJ Open<\/i> 2020; 10: e036454.","DOI":"10.1136\/bmjopen-2019-036454"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Suzuki M, Mineharu Y, Okawa M, et al. Common and distinct risk profiles of asymptomatic extra- and intracranial atherosclerosis in the Nagahama cohort. <i>J Stroke Cerebrovasc Dis<\/i> 2024; 33: 107782.","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107782"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Ito T, Fujiyoshi A, Ohkubo T, et al. Asymptomatic intracranial vascular lesions and cognitive function in a general population of Japanese men: Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). <i>Cerebrovasc Dis<\/i> 2026; 55: 251\u2013261.","DOI":"10.1159\/000546882"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Bernecker L, Johnsen LH, Vangberg TR. Intracranial stenosis prediction using a small set of risk factors in the Troms\u00f8 Study. <i>BMC Med Inform Decis Mak<\/i> 2025; 25: 95.","DOI":"10.1186\/s12911-025-02896-x"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Uehara T, Tabuchi M, Mori E. Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. <i>Eur J Neurol<\/i> 2005; 12: 218\u2013222.","DOI":"10.1111\/j.1468-1331.2004.00959.x"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Park KY, Chung CS, Lee KH, et al. Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic korean population. <i>J Clin Neurol<\/i> 2006; 2: 29\u201333.","DOI":"10.3988\/jcn.2006.2.1.29"}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/20\/1\/20_ra.2026-0017\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:06:35Z","timestamp":1775880395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/20\/1\/20_ra.2026-0017\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.ra.2026-0017","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"ra.2026-0017"}}